Development of the "Peritoneal Dialysis First" model in Hong Kong

被引:0
作者
Yu, Alex Wai-Yin [1 ]
Chau, Ka-Foon [2 ]
Ho, Yiu-Wing [3 ]
Li, Philip Kam-Tao [4 ]
机构
[1] Alice Ho Miu Ling Nethersole Hosp, Dept Med, Tai Po, Hong Kong, Peoples R China
[2] Queen Elizabeth Hosp, Dept Med, Kowloon, Hong Kong, Peoples R China
[3] United Christian Hosp, Dept Med, Kwun Tong, Peoples R China
[4] Prince Wales Hosp, Dept Med & Therapeut, Shatin, Hong Kong, Peoples R China
来源
PERITONEAL DIALYSIS INTERNATIONAL | 2007年 / 27卷
关键词
PD-First policy; model; Hong kong;
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Maintenance dialysis is an expensive treatment modality for patients with end-stage renal-disease (ESRD). The number of patients on maintenance dialysis is rising rapidly and will reach 2.5 million globally by 2010. The predicted expenditure will be US$1 trillion. Since the 1960s, Hong Kong has faced financial restraints on the provision of dialysis. Continuous ambulatory peritoneal dialysis (CAPD) and automated peritoneal dialysis at home were found to be less expensive than in-centre chronic hemodialysis. The development of a "peritoneal dialysis first" (PD-First) policy has contributed significantly to a successful dialysis program in Hong Kong since 1960. Currently in Hong Kong, 80% of ESRD patients on maintenance dialysis are on PD, mainly CAPD; 20% are on hemodialysis. The success of the PD-First policy is a combination of accumulated experience of PD in each dialysis unit that has at least 200 CAPD patients under care and of impressive technique and patient survival rates for this modality. Concerted effort by government and charity organizations and commitment on the part of nephrologists and nursing staff to patient education are also important in making the PD program in Hong Kong a successful one.
引用
收藏
页码:S53 / S55
页数:3
相关论文
共 5 条
[1]   CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS (CAPD) - EXPERIENCE WITH THE 1ST 100 PATIENTS IN A HONG-KONG CENTER [J].
CHAN, MK ;
LAM, SS ;
CHAN, PCK ;
CHENG, IKP .
INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 1987, 10 (02) :77-82
[2]   Healthcare systems and end-stage renal disease (ESRD) therapies - an international review: costs and reimbursement/funding of ESRD therapies [J].
De Vecchi, AF ;
Dratwa, M ;
Wiedemann, ME .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 1999, 14 :31-41
[3]  
DEFIJTER CWH, 1991, ADV PERIT D, V7, P186
[4]  
Lysaght MJ, 2002, J AM SOC NEPHROL, V13, pS37
[5]  
*REN REG WORK GROU, 2007, HONG KONG J IN PRESS